The Claim
Creatine monohydrate (5g/day) as an adjunct to cognitive-behavioral therapy for depression in adults aged 18–45 with moderate to severe symptoms is a feasible and acceptable intervention in under-resourced settings, with no evidence of increased adverse events or dropout rates.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Adding 5 grams of creatine monohydrate daily to cognitive-behavioral therapy for depression in adults aged 18–45 with moderate to severe symptoms is feasible and acceptable in under-resourced settings, and does not increase adverse events or dropout rates.
See the scientific wording
Creatine monohydrate (5g/day) as an adjunct to cognitive-behavioral therapy for depression in adults aged 18–45 with moderate to severe symptoms is a feasible and acceptable intervention in under-resourced settings, with no evidence of increased adverse events or dropout rates.
Creatine helps brain cells store and use energy more efficiently, which supports stable mood and mental effort during therapy, making it easier to stick with treatment without side effects.
What the research says
1 studyIn a small study, people with depression who took creatine along with therapy didn’t quit treatment or have more side effects than those who took a fake pill — meaning creatine is safe and practical to use even in places with few mental health resources.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.